0NZY.L - Eckert & Ziegler Strahlen- und Medizintechnik AG
Eckert & Ziegler Strahlen- und Medizintechnik AG
Robert-Rössle-Strasse 10
Berlin 13125
Germany
49 30 94 10 84 0
https://www.ezag.com
Settore/i:
Settore:
Impiegati a tempo pieno: 976
Figure dirigenziali chiave
| Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
|---|---|---|---|---|
| Dr. Andreas Eckert Ph.D. | Founder, Chairman of Exec. Board & CEO | 401,37k | N/D | 1960 |
| Dr. Harald Hasselmann | Head of Radiation Therapy Segment & Member of the Exec. Board - Medical Segment | 293,11k | N/D | 1967 |
| Dr. Lutz Helmke | Member of Exec. Board - Medical Segment | 255,03k | N/D | 1961 |
| Ms. Jutta Ludwig | Member of Exec. Board - Asia Bus. | 24k | N/D | 1953 |
| Dr. Hakim Bouterfa | Chief Medical Officer, Head of Clinical Devel. & Member of the Exec. Board | N/D | N/D | 1962 |
| Dr. Gunnar Mann | Head of Intragroup Services | N/D | N/D | 1967 |
| Mr. Franklin B. Yeager | Pres of Eckert & Ziegler Isotope Products Inc. | N/D | N/D | N/D |
| Ivan Simmer | Managing Director of Eckert & Ziegler Cesio s.r.o. | N/D | N/D | N/D |
| Mr. Joseph Hathcock | VP of Eckert & Ziegler Isotope Products Inc. | N/D | N/D | N/D |
Descrizione
Eckert & Ziegler Strahlen- und Medizintechnik AG, through its subsidiaries, manufactures and sells isotope technology components for medical, scientific, and industrial applications worldwide. It operates in two segments, Medical and Isotope Products. The Medical segment offers small radioactive implants for the treatment of prostate cancer seeds; and eye application based on ruthenium-106 or iodine-125 for treating uveal melanoma. This segment also provides radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-control equipment, and other consumables. The Isotope Products segment manufactures and sells standard and radiation sources for medical and industrial sectors. This segment offers calibration related sources for radioisotopes. Eckert & Ziegler Strahlen- und Medizintechnik AG was founded in 1992 and is based in Berlin, Germany.
Governance aziendale
L'ISS Governance QualityScore di Eckert & Ziegler Strahlen- und Medizintechnik AG al 1 giugno 2023 è 6. I criteri di valutazione fondamentali sono revisione: 6; Consiglio di Amministrazione: 6; diritti degli azionisti: 1; retribuzione: 7.
